Back

Comparing DOACs and warfarin in atrial fibrillation patients with bioprosthetic valves: a systematic review and meta-analysis

29 August 2025 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: The fear for stroke Device Treatment ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Ms Norma Gamarra Valverde

Lima (Peru)

7 More presentations in this session

Presentation thumbnail
Is pre-procedural Transesophageal echocardiography necessary in patients undergoing catheter ablation for atrial fibrillation under uninterrupted anticoagulation?
Doctor S. Mohanty (Austin, US)
Abstract Slides Video
Presentation thumbnail
Role of left atrial appendage occlusion versus direct oral anticoagulants in elderly patients (>80 years) with atrial fibrillation: a retrospective cohort analysis
Doctor M. Hunjul (Nablus, PS)
Abstract Slides Video
Presentation thumbnail
Management of oral anticoagulation after pulsed-field ablation for atrial fibrillation: Insights from a multi-center study
Doctor S. Mohanty (Austin, US)
Abstract Slides Video
Presentation thumbnail
Device-related thrombus post WATCHMAN implantation in the real world: lessons from a prospective multicenter registry of high-volume operators in the US
Doctor W. Saliba (Cleveland, US)
Abstract Slides Video
Presentation thumbnail
Adherence to imaging guidelines post WATCHMAN implantation in the real world: lessons from a multicenter prospective registry of high-volume operators in the US
Doctor W. Jaber (Cleveland, US)
Abstract Slides Video

Access the full session

Session thumbnail
The fear for stroke

The Event

Event poster

ESC Congress 2025

29 August 2025 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Direct oral anticoagulants versus vitamin k antagonists in patients with atrial fibrillation and bioprosthesis: a systematic review and meta-analysis
thumbnail
Congress Presentation
The efficacy and safety of edoxaban compared to warfarin in patients with atrial fibrillation with different clinical phenotypes: a meta-analysis of randomized controlled trials
thumbnail
Congress Presentation
Anticoagulation strategy of choice for atrial fibrillation ablation - a network meta-analysis of complication rates

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources